-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 QHI9hckYVV0YzcBPuwpUCGxR2fqGYTXQ5XkI7K6IPBduBPLovJve4ATb+WUg66ps
 RAchMN2tvbwWqf/4s0eTcg==

<SEC-DOCUMENT>0000899140-08-001308.txt : 20080610
<SEC-HEADER>0000899140-08-001308.hdr.sgml : 20080610
<ACCEPTANCE-DATETIME>20080610163853
ACCESSION NUMBER:		0000899140-08-001308
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20010715
FILED AS OF DATE:		20080610
DATE AS OF CHANGE:		20080610

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ACCESS PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0000318306
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				830221517
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		2600 N STEMMONS FRWY
		STREET 2:		STE 176
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75207
		BUSINESS PHONE:		2149055100

	MAIL ADDRESS:	
		STREET 1:		2600 N STEMMONS FRWY
		STREET 2:		STE 176
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75207

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHEMEX PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHEMEX CORP/WY
		DATE OF NAME CHANGE:	19831102

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Oracle Associates LLC
		CENTRAL INDEX KEY:			0001317217
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-15771
		FILM NUMBER:		08891178

	BUSINESS ADDRESS:	
		STREET 1:		200 GREENWICH AVENUE, 3RD FLOOR
		CITY:			GREENWICH
		STATE:			CT
		ZIP:			06830
		BUSINESS PHONE:		203-862-1660

	MAIL ADDRESS:	
		STREET 1:		200 GREENWICH AVENUE, 3RD FLOOR
		CITY:			GREENWICH
		STATE:			CT
		ZIP:			06830
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>orassoc_accp3-060208ex.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0202</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2001-07-15</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0000318306</issuerCik>
        <issuerName>ACCESS PHARMACEUTICALS INC</issuerName>
        <issuerTradingSymbol>ACCP</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001317217</rptOwnerCik>
            <rptOwnerName>Oracle Associates LLC</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>200 GREENWICH AVENUE, 3RD FLOOR</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>GREENWICH</rptOwnerCity>
            <rptOwnerState>CT</rptOwnerState>
            <rptOwnerZipCode>06830</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Common Stock, par value $0.01 per share (&quot;Common Stock&quot;)</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>900400</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>See footnote</value>
                    <footnoteId id="F1"/>
                </natureOfOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <derivativeTable>
        <derivativeHolding>
            <securityTitle>
                <value>7% Convertible Subordinated Notes, due Sept. 7, 2005</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>5.50</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <value>2001-09-13</value>
            </exerciseDate>
            <expirationDate>
                <value>2005-09-13</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>586000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>See footnote</value>
                    <footnoteId id="F2"/>
                </natureOfOwnership>
            </ownershipNature>
        </derivativeHolding>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">See Exhibit 99.1.</footnote>
        <footnote id="F2">See Exhibit 99.1.</footnote>
    </footnotes>

    <remarks>Exhibit List:

Exhibit 99.1 - Explanation of Responses</remarks>

    <ownerSignature>
        <signatureName>ORACLE ASSOCIATES, LLC, By: /s/ Larry N. Feinberg, Managing Member</signatureName>
        <signatureDate>2008-06-10</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>2
<FILENAME>o4190810.txt
<DESCRIPTION>99.1 - EXPLANATION OF RESPONSES
<TEXT>


                                                                    Exhibit 99.1


                            Explanation of Responses


(1)  The shares of Common Stock to which this note relates are held directly by
     Oracle Institutional Partners ("Oracle Institutional") and Oracle Partners.
     ("Oracle Partners"). Oracle Associates, LLC ("Oracle Associates") serves as
     the general partner to Oracle Institutional and Oracle Partners. Mr. Larry
     N. Feinberg ("Mr. Feinberg") serves as the senior managing member of Oracle
     Associates, LLC, as the sole shareholder and president of Oracle Investment
     Management, Inc. and as the trustee of The Feinberg Family Foundation. In
     accordance with Instruction 5(b)(v), the entire number of shares of Common
     Stock and Notes held by Oracle Institutional and Oracle Partners is
     reported herein. Oracle Associates disclaims any beneficial ownership of
     the securities held by Oracle Institutional and Oracle Partners for
     purposes of Section 16 of the Securities Exchange Act of 1934, except to
     the extent of Oracle Associates' pecuniary interest. Any further
     transactions in securities of the issuer required to be reported by Oracle
     Associates will be reported in joint filings with Mr. Feinberg on Form 4.

(2)  The Convertible Notes to which this note relates are held directly by
     Oracle Institutional and Oracle Partners. Oracle Institutional's
     Convertible Note is convertible into 127,000 shares of Common Stock and
     Oracle Partners' Convertible Note is convertible into 459,000 shares of
     Common Stock.


</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
